HK Stocks Oct 27 Close: HSI Down 0.73%, HSBC Tumbles Post-Earnings, Zhipu Up Nearly 9%
nashnova research
The Hang Seng Index fell 0.73% to 23,041 as HSBC's below-consensus Q3 revenue triggered a 5.56% sell-off; funds rotated into high-dividend bank and coal names while offshore geopolitical and U.S. election risks weighed on sentiment.
Why did Hong Kong stocks open high and close low?
All three benchmarks fell: the HSI lost 0.73% to 23,041, the Hang Seng Tech Index dropped 1.48%, and turnover hit HK$178.3 billion.
Soochow Securities flagged two persistent offshore risks: recurring U.S.–Iran tensions and growing market bets that Democrats will take both chambers in the midterms.
This means → the weakness is sentiment-driven, not fundamental — Hong Kong stocks are being dragged by external risk appetite.
What went wrong with HSBC?
Q3 pre-tax profit reached US$9.6 billion, up 32% year-on-year, but missed the US$9.7 billion consensus; revenue of US$18.6 billion also fell short of the US$18.93 billion estimate.
In plain terms = the numbers were decent, but the market wanted more — "good but not good enough" became a negative catalyst.
Shares slid 5.56% to HK$134.3 on HK$4.97 billion in turnover. Per Bloomberg, the result also dragged the Euro Stoxx 600 banks sub-index, with HSBC falling 6.2% in European trading.
Where did the money go — why did high-yield stocks buck the trend?
Mainland banks and coal rallied: Minsheng Bank rose 2.75%, ICBC gained 2.15%, and China Shenhua added 2.36%.
This means → when uncertainty rises, capital shifts from growth tech into low-valuation, high-dividend defensive plays.
Changjiang Securities noted that bank stocks remain in a low-valuation repair and dividend re-rating process; short-term style rotation does not alter the direction. JPMorgan added that traditional HK utility stocks may outperform if volatility persists.
Why were innovative pharma and property developers under pressure?
Innovative pharma led declines: Connect Biopharma fell 14.38%, LeapBio dropped 5.31%, and SSY Group lost 5.03%.
Property developers weakened in tandem: Midea Real Estate fell 6.79%, Sunac China slid 6.06%. Per BOCI, week-43 new-home transactions across 47 cities totaled 2.468 million sqm, down 34.8% year-on-year — the decline widened by 10.7 percentage points from the prior week.
Industrial Securities argued that "innovation + globalization" remains the core pharma theme for 2026, and the pullback has made valuations more attractive.
Which names moved against the tide?
Zhipu (02513) surged 8.90% to HK$550.5, boosted by Anthropic filing its IPO prospectus with a target valuation of US$2 trillion, lifting AI sentiment.
ZTE (00763) rose 4.40% post-earnings — Q3 net profit hit RMB 1.307 billion, up 394.46% year-on-year. Li Ning (02331) gained 5.92% after flagging a potential special dividend.
Yue Yuen (00551) plunged 9.93% after a profit warning: H1–Q3 net profit is expected to drop roughly 50%–55% year-on-year, dragged by tariffs, rising labor costs, and uneven capacity utilization.
What to watch next?
The day's core narrative was HSBC's earnings drag plus tighter offshore risk appetite — the two combined to cap any rebound.
Whether the rotation into high-dividend defensive names continues hinges on two things: the rest of U.S. earnings season and the trajectory of geopolitical risk.
In plain terms = the short-term mood follows offshore cues; the medium-term question is whether this defensive tilt is structural or just a brief shelter from the storm.
市场有风险，内容仅供研究参考，不构成投资建议。